Skip to content

Percutaneous transforaminal endoscopic discectomy for the treatment of degenerative lumbar disc herniation in older adult patients

Percutaneous transforaminal endoscopic discectomy for the treatment of degenerative lumbar disc herniation in older adult patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016399
Enrollment
Unknown
Registered
2018-05-30
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation (LDH)

Interventions

Prone position group:Percutaneous transforaminal endoscopic discectomy
Lateral position group:Percutaneous transforaminal endoscopic discectomy

Sponsors

Dalian Municipal Central Hospital Affiliated to Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with initially diagnosed LDH undergoing initial surgery; 2. Aged 60-75 years; 3. Lowe back pain or radiating pain in the lower limbs, positive physical sign consistent with imaging data; 4. No improvement or aggravation in symptoms after 3 months of non-surgical treatment; 5. Provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1. A history of severe circulatory or respiratory system diseases; 2. No obvious abnormality in electrocardiogram and lung function test; 3. Cardiac ejection = 60%; 4. Clinical manifestation of lumbar spondylolisthesis and lumbar instability; 5. Spinal cord injury or nerve injury.

Design outcomes

Primary

MeasureTime frame
Oswestry Disability Index;

Secondary

MeasureTime frame
Oswestry Disability Index;X-ray morphology of the lumbar spine;Modified MacNab grade;Visual Analog Score;Japanese Orthopaedic Association (JOA) score;Partial pressures of oxygen and carbon dioxide;Mean arterial pressure;Likert score;Times and doses of vasopressor drugs used;Incidence of recurrent LDH;Incidence of adverse reactions;

Countries

China

Contacts

Public ContactLichen Xu

Dalian Municipal Central Hospital Affiliated to Dalian Medical University

86371113@qq.com+86 13889556335

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026